BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jhang JF, Jiang YH, Hsu YH, Ho HC, Kuo HC. Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis/bladder pain syndrome patients with Hunner's lesion and grade 3 glomerulation might be different from other types of patients. Int J Urol 2021;28:823-30. [PMID: 33966299 DOI: 10.1111/iju.14585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kamasako T, Kaga K, Inoue KI, Hariyama M, Yamanishi T. Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients. Int J Urol 2022. [PMID: 35102612 DOI: 10.1111/iju.14795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jhang J, Ho H, Jiang Y, Hsu Y, Kuo H. Clinical Correlation of Bladder Electron Microscopic Characteristics in Patients with Detrusor Underactivity of Various Etiologies. Biomedicines 2022;10:1055. [DOI: 10.3390/biomedicines10051055] [Reference Citation Analysis]
3 Ueda T. Editorial Comment from Dr Ueda to Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis/bladder pain syndrome patients with Hunner's lesion and grade 3 glomerulation might be different from other types of patients. Int J Urol 2021;28:831-2. [PMID: 34169591 DOI: 10.1111/iju.14621] [Reference Citation Analysis]
4 Jiang Y, Jhang J, Lee Y, Kuo H. Low-Energy Shock Wave Plus Intravesical Instillation of Botulinum Toxin A for Interstitial Cystitis/Bladder Pain Syndrome: Pathophysiology and Preliminary Result of a Novel Minimally Invasive Treatment. Biomedicines 2022;10:396. [DOI: 10.3390/biomedicines10020396] [Reference Citation Analysis]
5 Jiang YH, Jhang JF, Lin TY, Ho HC, Hsu YH, Kuo HC. Therapeutic Efficacy of Intravesical Platelet-Rich Plasma Injections for Interstitial Cystitis/Bladder Pain Syndrome-A Comparative Study of Different Injection Number, Additives and Concentrations. Front Pharmacol 2022;13:853776. [PMID: 35392571 DOI: 10.3389/fphar.2022.853776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yoshimura N, Uno T, Sasaki M, Ohinata A, Nawata S, Ueda T. The O'Leary-Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP-116D, 50% dimethyl sulfoxide solution. Int J Urol 2021. [PMID: 34929761 DOI: 10.1111/iju.14765] [Reference Citation Analysis]